IN2014DN10328A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN10328A IN2014DN10328A IN10328DEN2014A IN2014DN10328A IN 2014DN10328 A IN2014DN10328 A IN 2014DN10328A IN 10328DEN2014 A IN10328DEN2014 A IN 10328DEN2014A IN 2014DN10328 A IN2014DN10328 A IN 2014DN10328A
- Authority
- IN
- India
- Prior art keywords
- telaprevir
- boceprevir
- peptides
- synthetic routes
- preparing
- Prior art date
Links
- 229960002935 telaprevir Drugs 0.000 abstract 3
- 108010017101 telaprevir Proteins 0.000 abstract 3
- BBAWEDCPNXPBQM-GDEBMMAJSA-N telaprevir Chemical compound N([C@H](C(=O)N[C@H](C(=O)N1C[C@@H]2CCC[C@@H]2[C@H]1C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1)C(C)(C)C)C1CCCCC1)C(=O)C1=CN=CC=N1 BBAWEDCPNXPBQM-GDEBMMAJSA-N 0.000 abstract 3
- 229960000517 boceprevir Drugs 0.000 abstract 2
- LHHCSNFAOIFYRV-DOVBMPENSA-N boceprevir Chemical compound O=C([C@@H]1[C@@H]2[C@@H](C2(C)C)CN1C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C)NC(C(=O)C(N)=O)CC1CCC1 LHHCSNFAOIFYRV-DOVBMPENSA-N 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 238000003799 Mukaiyama Aldol addition reaction Methods 0.000 abstract 1
- 150000002466 imines Chemical class 0.000 abstract 1
- -1 silyl enol ether Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/02—Formation of carboxyl groups in compounds containing amino groups, e.g. by oxidation of amino alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/10—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention relates to synthetic routes for preparing telaprevir and boceprevir and its intermediates as well as peptides other than telaprevir. The synthetic routes are based on a Mukaiyama aldol addition reaction of a silyl enol ether or an enolate with an imine. The invention also refers to novel intermediates for preparing telaprevir/boceprevir or other peptides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12172775 | 2012-06-20 | ||
PCT/EP2013/062737 WO2013189980A1 (en) | 2012-06-20 | 2013-06-19 | SYNTHESIS OF TELAPREVIR AND BOCEPREVIR, OR PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATES AS WELL AS INTERMEDIATE PRODUCTS THEREOF INCLUDING ß-AMINO ACIDS PREPARED VIA MUKAIYAMA ALDOL ADDITION |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN10328A true IN2014DN10328A (en) | 2015-08-07 |
Family
ID=48652093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN10328DEN2014 IN2014DN10328A (en) | 2012-06-20 | 2013-06-19 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9346853B2 (en) |
EP (1) | EP2864321A1 (en) |
CN (1) | CN104470914A (en) |
IN (1) | IN2014DN10328A (en) |
RU (1) | RU2014151613A (en) |
WO (1) | WO2013189980A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085310B (en) * | 2014-05-15 | 2017-05-10 | 重庆汇智药物研究院有限公司 | New synthesis method of telaprevir intermediate |
WO2024015574A1 (en) * | 2022-07-14 | 2024-01-18 | Jnana Therapeutics Inc. | Small molecule inhibitors of mammalian slc6a19 function |
WO2024118721A1 (en) * | 2022-11-30 | 2024-06-06 | Jnana Therapeutics Inc. | Crystalline forms of a piperidine inhibitor of slc6a19 function |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR044694A1 (en) | 2003-06-17 | 2005-09-21 | Schering Corp | PROCESS AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF (1R, 2S, 5S) - 3 AZABICICLO [3,1,0] HEXANO-2- CARBOXAMIDE, N- [3- AMINO-1- (CYCLLOBUTILMETILE) - 2, 3 - DIOXOPROPIL] -3- [(2S) - 2 - [[[1,1- DIMETHYTILE] AMINO] CARBONYLAMINE] -3,3-DIMETHYL -1- OXOBUTIL] -6.6 DIMETHYL |
PL1934179T4 (en) | 2005-08-19 | 2014-03-31 | Vertex Pharma | Processes and intermediates |
KR101398259B1 (en) | 2006-03-16 | 2014-05-26 | 버텍스 파마슈티칼스 인코포레이티드 | Processes and intermediates for preparing steric compounds |
EP2039689A4 (en) | 2006-05-26 | 2011-12-28 | Kaneka Corp | Process for production of optically active 3-amino-2 -hydroxypropionic cyclopropylamide derivatives and salts thereof |
WO2009114633A1 (en) | 2008-03-12 | 2009-09-17 | Virobay, Inc. | Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives |
WO2009152474A2 (en) | 2008-06-13 | 2009-12-17 | Virobay, Inc. | Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives |
-
2013
- 2013-06-19 IN IN10328DEN2014 patent/IN2014DN10328A/en unknown
- 2013-06-19 US US14/408,465 patent/US9346853B2/en not_active Expired - Fee Related
- 2013-06-19 RU RU2014151613A patent/RU2014151613A/en unknown
- 2013-06-19 CN CN201380032537.XA patent/CN104470914A/en active Pending
- 2013-06-19 EP EP13729738.8A patent/EP2864321A1/en not_active Withdrawn
- 2013-06-19 WO PCT/EP2013/062737 patent/WO2013189980A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2864321A1 (en) | 2015-04-29 |
US9346853B2 (en) | 2016-05-24 |
WO2013189980A1 (en) | 2013-12-27 |
CN104470914A (en) | 2015-03-25 |
US20150183824A1 (en) | 2015-07-02 |
RU2014151613A (en) | 2016-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201900948PA (en) | Modified nucleotide linkers | |
CL2016000460A1 (en) | Gitr antigen binding proteins | |
SG10201902924RA (en) | Antibodies that bind ebola glycoprotein and uses thereof | |
MX2018010572A (en) | Hetero-dimeric immunoglobulins. | |
MX2011011925A (en) | Tri- or tetraspecific antibodies. | |
IN2014DN08481A (en) | ||
PH12014501427B1 (en) | Anti-phf-tau antibodies and their uses | |
NZ726859A (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
MX347454B (en) | Inhibitory anti -factor xii/xiia monoclonal antibodies and their uses. | |
UA111827C2 (en) | METHOD OF OBTAINING INHENOL-3-ANGELATE | |
UA106900C2 (en) | LibreOfficeDR5-BINDING POLYPEPTIDE | |
MX346500B (en) | Methods and compositions for neural disease immunotherapy. | |
IN2012MU03723A (en) | ||
JO3771B1 (en) | Intermediates for the preparation of sacubitril and their preparation | |
MX369662B (en) | Microalgal flour granules and process for preparation thereof. | |
MX2017007381A (en) | Binding members for human c-maf. | |
AU2014324499A8 (en) | Novel synthesis routes for prostaglandins and prostaglandin intermediates using metathesis | |
MY176465A (en) | Synthetic route to 2?-deoxy-2?,2?-difluorotetrahydrouridines | |
IN2014DN07983A (en) | ||
IN2013MN00733A (en) | ||
IN2014DN10328A (en) | ||
MY175464A (en) | Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crytalline forms thereof | |
PH12016501201A1 (en) | Synthesis of ent-progesterone and intermediates thereof | |
PH12017500499A1 (en) | Synthesis of ent-progesterone and intermediates thereof | |
EA201590778A1 (en) | CLEANING OF COMBINED GALACTOCEREBROZIDE-β-GALAKTOSIDASE OF MAN |